Pharmaceutical

Cidara axes 30% of staff to focus on flu prevention drug

The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.

Sep 14, 2024 - 04:00
Cidara axes 30% of staff to focus on flu prevention drug
The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.
Read the original article

Tags:

Previous Article

Oncternal stock crashes by 60% as it lays off staff and scraps trials

Next Article

Sobi and Enable Injections partner for Aspaveli distribution

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Idorsia introduces Quviviq in Switzerland for chronic insomnia treatment

Idorsia introduces Quviviq in Switzerland for chronic i...

Jun 13, 2023

CDC advisory panel backs changes to Covid vaccination policy

CDC advisory panel backs changes to Covid vaccination p...

Apr 19, 2023

FDA approves over-the-counter Narcan. Here’s what it means

FDA approves over-the-counter Narcan. Here’s what it means

Mar 30, 2023